Analysts on Wall Street project that JPMorgan Chase & Co. (JPM) will announce quarterly earnings of $5.01 per share in its forthcoming report, representing an increase of 4.2% year over year. Revenues are projected to reach $45.71 billion, increasing 6.9% from the same quarter last year.Over the last 30 days, there has been an upward revision of 1% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial fo ...

Core Insights - Wall Street analysts forecast a quarterly loss of -$0.17 per share for Rubrik, Inc. (RBRK), representing a year-over-year increase of 19.1% in losses. Revenue is expected to reach $320.93 million, reflecting a 35.9% increase compared to the same quarter last year [1]. Earnings Estimates - Over the past 30 days, the consensus EPS estimate has been adjusted upward by 1.8%, indicating a collective reassessment by covering analysts [2]. - Revisions to earnings estimates are crucial for predicting investor actions regarding the stock, with empirical research showing a strong correlation between earnings estimate trends and short-term stock price performance [3]. Revenue Projections - Analysts predict 'Revenue- Subscription' will reach $309.06 million, indicating a year-over-year change of +39.5% [4]. - 'Revenue- Other' is expected to be $10.44 million, showing a +1.1% change from the prior-year quarter. Conversely, 'Revenue- Maintenance' is projected at $1.57 million, reflecting a significant year-over-year decline of -63.8% [5]. - 'Cloud ARR' is projected to reach $1,136,975, contrasting with the year-ago figure of $768,838 [5]. Key Company Metrics - The combined assessment suggests 'Subscription ARR' will likely reach $1,321,722, compared to $1,002,252 in the same quarter last year. Additionally, 'Customers with $100K or more in Subscription ARR' is expected to reach 2,650, up from 2,085 in the same quarter last year [6]. - Over the past month, Rubrik, Inc. shares have recorded a return of -7.9%, while the Zacks S&P 500 composite changed by -0.5%. The company holds a Zacks Rank 3 (Hold), indicating it is likely to perform in line with the overall market in the upcoming period [6].

Core Insights - Analysts project Nutanix (NTNX) will report quarterly earnings of $0.41 per share, a decline of 2.4% year over year, with revenues expected to reach $677.2 million, an increase of 14.6% from the same quarter last year [1] Earnings Estimates - Over the last 30 days, the consensus EPS estimate has been revised downward by 1.8%, indicating a collective reconsideration by analysts [2] - Changes in earnings estimates are crucial for predicting investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock performance [3] Revenue Projections - Analysts estimate 'Revenue- Support, entitlements and other services' at $326.26 million, reflecting a year-over-year change of +12.9% [5] - 'Revenue- Product' is expected to be $350.98 million, indicating a year-over-year change of +16.3% [5] - The consensus for 'Disaggregation of Revenue- Professional services revenue' stands at $29.73 million, a change of +9% from the prior-year quarter [5] - 'Disaggregation of Revenue- Subscription revenue' is projected to reach $642.75 million, with a year-over-year change of +14.6% [6] Geographic Revenue Estimates - 'Geographic Revenue- U.S.' is expected to be $379.71 million, reflecting a +14.1% change from the year-ago quarter [7] - 'Geographic Revenue- Europe, the Middle East and Africa' is projected at $162.01 million, indicating a +7.2% change [6] - 'Geographic Revenue- Other Americas' is estimated at $18.57 million, showing a significant +65.5% change [7] - 'Geographic Revenue- Asia Pacific' is forecasted to reach $114.76 million, a +19.8% change from the year-ago quarter [7] Key Metrics - The average prediction for 'Annual Recurring Revenue (ARR)' is $2.27 billion, up from $1.97 billion in the same quarter last year [8] - 'Total Billings' is expected to arrive at $715.52 million, compared to $591.40 million a year ago [8] - Analysts suggest 'Total end customers' will likely reach 29,844, an increase from 27,160 in the same quarter last year [9] Stock Performance - Nutanix shares have returned -12.2% over the past month, contrasting with the Zacks S&P 500 composite's -0.3% change [9] - The company holds a Zacks Rank 3 (Hold), indicating it is expected to mirror overall market performance in the near future [9]

Core Viewpoint - Analysts project that Dolby Laboratories (DLB) will report quarterly earnings of $0.70 per share, reflecting a year-over-year decline of 13.6%, with revenues expected to reach $305.38 million, a slight increase of 0.2% from the same quarter last year [1]. Revenue Estimates - The consensus estimate for 'Revenue- Licensing' is $280.87 million, indicating a decrease of 0.7% from the prior-year quarter [4]. - 'Revenue- Products and services' is expected to be $24.50 million, showing an increase of 10.9% from the year-ago quarter [4]. - 'Revenue- Licensing- Market- PC' is projected at $27.12 million, suggesting a decline of 20.4% year over year [4]. - 'Revenue- Licensing- Market- Other' is anticipated to reach $78.82 million, reflecting an increase of 26.9% from the prior-year quarter [5]. - 'Revenue- Licensing- Market- CE' is expected to be $30.72 million, indicating a decrease of 26.9% from the year-ago quarter [5]. - 'Revenue- Licensing- Market- Broadcast' is projected at $91.88 million, showing a decline of 4.1% from the prior-year quarter [6]. - 'Revenue- Licensing- Market- Mobile' is expected to be $53.77 million, reflecting an increase of 10.4% from the year-ago quarter [6]. Gross Margin Estimates - 'Gross Margin- Licensing' is estimated at $260.57 million, compared to $263.94 million from the previous year [7]. - 'Gross margin- Products and services' is projected to reach $2.30 million, down from $6.87 million reported in the same quarter last year [7]. Stock Performance - Dolby Laboratories shares have decreased by 2.8% over the past month, contrasting with the Zacks S&P 500 composite's increase of 4.6% [7].

Core Insights - Groupon reported revenue of $122.83 million for Q3 2025, a year-over-year increase of 7.3%, but an EPS of -$2.92 compared to $0.33 a year ago, indicating significant losses [1] - The revenue exceeded the Zacks Consensus Estimate of $121.88 million by 0.77%, while the EPS fell short of the consensus estimate of $0.01 by 29300% [1] Financial Performance - The company’s stock has returned -7.5% over the past month, contrasting with the Zacks S&P 500 composite's +1.3% change, and currently holds a Zacks Rank 3 (Hold) [3] - North America revenue was $96.01 million, surpassing the two-analyst average estimate of $92.32 million, reflecting a year-over-year change of +10.5% [4] - International revenue was $26.82 million, slightly below the two-analyst average estimate of $27.62 million, showing a year-over-year decline of -2.8% [4] Geographic Revenue Breakdown - North America Local revenue reached $91.56 million, exceeding the average estimate of $87.82 million, with a year-over-year increase of +12.4% [4] - International Goods revenue was $2.18 million, below the average estimate of $2.84 million, marking a year-over-year decrease of -20.5% [4] - North America Goods revenue fell to $1.22 million, significantly lower than the estimated $1.63 million, representing a -50.9% change year over year [4] - International Local revenue was $23.18 million, slightly above the average estimate of $23.15 million, with a year-over-year change of -1.2% [4] - International Travel revenue was $1.46 million, below the average estimate of $1.63 million, but showing a year-over-year increase of +5.6% [4] - North America Travel revenue increased to $3.22 million, surpassing the estimated $2.87 million, reflecting a +10.4% change year over year [4]

Core Insights - Bio-Techne Corporation (TECH) reported first-quarter fiscal 2026 adjusted earnings per share (EPS) of 42 cents, matching the Zacks Consensus Estimate, with the bottom line remaining flat year-over-year [1][9] - The company's net sales for the quarter were $286.6 million, down 1% year-over-year, missing the Zacks Consensus Estimate by 0.9%, leading to a 7.5% drop in shares during pre-market trading [3][9] Financial Performance - GAAP loss per share was 24 cents compared to EPS of 21 cents in the prior-year quarter [2] - Gross profit increased by 2.8% to $188.1 million, with gross margin expanding by 242 basis points to 65.6% due to a 7.5% decrease in the cost of sales [6][9] - Operating profit for the quarter was $47.7 million, up from $40 million in the year-ago quarter, with an operating margin expansion of 282 basis points to 16.6% [7][9] - Net cash provided by operating activities was $27.6 million, down from $63.9 million a year ago [10] Revenue Breakdown - In the Protein Sciences segment, revenues were $202.2 million, down 1% year-over-year (down 3% organically) [4] - The Diagnostics and Spatial Biology segment saw sales decrease by 4% year-over-year to $79.5 million, although it was up 3% organically [5] Market Position and Outlook - Despite the revenue decline, there are signs of stabilization in the U.S. academic market and continued strength among large pharmaceutical customers [11] - The expansion of both gross and operating margins is viewed as a positive indicator for the company's future performance [12]

Analysts on Wall Street project that JFrog Ltd. (FROG) will announce quarterly earnings of $0.16 per share in its forthcoming report, representing an increase of 6.7% year over year. Revenues are projected to reach $128.4 million, increasing 17.7% from the same quarter last year.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Before a company announces ...

Core Insights - Robinhood Markets (HOOD) is set to announce its Q3 earnings results on November 5th, focusing on net deposits [5] - The consensus GAAP EPS estimate for the quarter is $0.54, while the consensus revenue estimate stands at $1.22 billion, reflecting a year-over-year increase of 91.5% [5]

Core Insights - Hamilton Lane (HLNE) reported a revenue of $190.88 million for the quarter ended September 2025, reflecting a year-over-year increase of 27.3% and exceeding the Zacks Consensus Estimate of $166.82 million by 14.43% [1] - The company's earnings per share (EPS) for the quarter was $1.54, up from $1.07 in the same quarter last year, representing a surprise of 42.59% compared to the consensus estimate of $1.08 [1] Financial Performance Metrics - Fee Earning AUM for Customized Separate Accounts (CSA) was reported at $40.8 billion, slightly below the average estimate of $41.29 billion [4] - Total Fee Earning AUM stood at $76.42 billion, compared to the estimated $76.99 billion [4] - Fee Earning AUM for Specialized Funds (SF) was $35.62 billion, close to the average estimate of $35.7 billion [4] - Total AUM & AUA reached $1005.2 billion, compared to the average estimate of $1008.53 billion [4] - Assets Under Management (AUM) were reported at $145.36 billion, exceeding the average estimate of $144.22 billion [4] - Assets Under Advisement (AUA) totaled $859.84 billion, slightly below the average estimate of $864.31 billion [4] Revenue Breakdown - Incentive fees revenue was $44.55 million, significantly higher than the average estimate of $26.55 million, marking a year-over-year increase of 47.4% [4] - Management and advisory fees for Customized Separate Accounts were $35.77 million, slightly above the estimated $34.82 million, reflecting a 2.9% increase year-over-year [4] - Total management and advisory fees revenue was $142.13 million, surpassing the average estimate of $139.9 million, with an 18.7% year-over-year increase [4] - Management and advisory fees for Specialized Funds reached $89.86 million, exceeding the average estimate of $87.97 million, representing a 27.8% year-over-year increase [4] - Fund reimbursement revenue was reported at $1.97 million, below the estimated $2.25 million, but still showing a 36.8% increase year-over-year [4] - Distribution management revenue was $0.45 million, significantly lower than the average estimate of $1.18 million, with an 8.7% year-over-year increase [4]

Core Insights - PPG Industries reported a third-quarter 2025 profit of $444 million or $1.96 per share, an increase from $1.90 per share a year ago, with adjusted earnings per share at $2.13, surpassing estimates [1][8] - The company's revenues reached $4,082 million, reflecting a 1.2% year-over-year increase and exceeding the Zacks Consensus Estimate of $4,036.1 million [1] Segment Review - The Global Architectural Coatings segment experienced a 1% year-over-year sales increase to $1,012 million, driven by higher selling prices and favorable foreign currency translation, despite divestitures and reduced sales volumes [2] - The Performance Coatings segment saw a 3% year-over-year sales rise to $1,414 million, although it missed estimates. The growth was attributed to higher selling prices and favorable currency translation, with organic sales growing 2% [3] - The Industrial Coatings segment's sales remained flat at $1,656 million, missing estimates due to the divestiture of the silicas products business and lower pricing offsetting higher volumes [4] Financials - As of the end of the quarter, PPG had $1,832 million in cash and cash equivalents, with net debt increasing to $5.4 billion, up $228 million from the previous year [5] Outlook - PPG anticipates adjusted earnings per share of $7.60 to $7.70 for the full year 2025, citing ongoing share gains and benefits from cost initiatives, with stronger performance expected in aerospace and protective coatings [6] Price Performance - PPG shares have declined by 16.8% over the past year, compared to an 8.7% decline in its industry [7]